Project: Advanced Inhalation Model for Drug Discovery on Chip
| Acronym | AIM4DoC (Reference Number: 12977) |
| Duration | 01/08/2019 - 03/08/2022 |
| Project Topic | ALVEOLIX together with partners aim to develop the world’s first inhalation exposure model on a lung-on-chip. AIM4DoC can be used for inhalation toxicology studies, environmental risk assessment, or pre-clinical safety assessment of new drugs. ALVEOLIX, expert for organ-on-chip technology, will join forces with VITROCELL, market leader for in-vitro exposure systems. After successful validation, this groundbreaking product will improve the drug discovery process and reduce animal testing. |
| Network | Eurostars 2 |
| Call | Eurostars Cut–off 10 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | AlveoliX AG | Coordinator | Switzerland |
| 2 | Universität Bern | Partner | Switzerland |
| 3 | VITROCELL Systems GmbH | Partner | Germany |
| 4 | Helmholtz-Zentrum für Infektionsforschung | Partner | Germany |